Advertisement
Home Blog Page 3480
Many Americans with type 2 diabetes may be getting unnecessary tests -- and

Excessive Testing May Be Compromising T2DM Care

0
In U.S. cohort, more than 60 percent received too many HbA1c tests
Cognitive behavioral therapy and antidepressants could both be equally effective as stand-alone treatments for major depressive disorder

Cognitive Therapy, Meds Equally Effective for Major Depression

0
Researchers find both treatments can benefit patients with major depressive disorder
For breast and colorectal cancer survivors

Mindfulness Tx Aids Cancer-Linked Cognitive Impairment

0
Benefits for breast and colorectal cancer survivors with mindfulness-based stress reduction
Cell-free circulating mitochondrial DNA from cerebrospinal fluid is reduced in patients with Parkinson's disease

Cell-Free Circulating mtDNA Identifies Parkinson’s Disease

0
Reduced CSF ccf-mtDNA in patients with Parkinson's versus age-matched asymptomatic controls
For patients undergoing cyclophotocoagulation

IOP Spikes Common After Cyclophotocoagulation

0
No preoperative, perioperative associations for post-cyclodiode spike within three hours post-op
The presence of medical students in the emergency department is associated with increased length of stay

Presence of Medical Students in ER Slightly Ups Length of Stay

0
Increase of about five minutes in ER length of stay is significant, but unlikely to be clinically relevant
For statin-intolerant patients with dyslipidemia with ischemic heart disease treated with percutaneous coronary intervention

Nutraceuticals Alone or With Ezetimibe Aid in Dyslipidemia

0
Improvement in lipid profile for nutraceuticals alone or in combo for statin-intolerant patients
The Dignitana DigniCap Cooling System cap has been approved by the U.S. Food and Drug Administration to help prevent hair loss in women undergoing chemotherapy for breast cancer.

FDA Approves Cooling Cap to Reduce Chemo-Linked Hair Loss

0
Designed for women diagnosed with breast cancer
β-blockers and angiotensin-converting enzyme inhibitors can prevent heart damage in breast cancer patients as they undergo chemotherapy

SABCS: β-Blockers, ACEIs May Protect Heart During Chemo

0
May also lower risk of complications that can interrupt breast cancer treatment
Capecitabine appears to reduce risk of recurrence for breast cancer patients with residual disease after presurgery chemotherapy

SABCS: Adding Capecitabine Ups Outcomes for Breast CA Patients

0
Linked to longer disease-free survival; second study links denosumab to reduced risk of recurrence